Company Search:
Advanced Search
Sponsored Links
Aurinia Pharmaceuticals Inc Company Snapshot
Aurinia Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aurinia Pharmaceuticals Inc with three other companies in this sector in Canada: Sirona Biochem Corp (2016 sales of 360,500.00 Canadian Dollars [US$289,791.53 ] ), Kaneh Bosm Biotechnology Inc (51,558.00 Canadian Dollars [US$41,445.41 ] ), and Vitality Products Inc (108,486.00 Canadian Dollars [US$87,207.56 ] ).

Sales Analysis. Aurinia Pharmaceuticals Inc reported sales of C$228,591.82 (US$183.76 thousand) for the year ending December of 2016. This represents a sharp decrease of 24.5% versus 2015, when the company's sales were C$302,710.55 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aurinia Pharmaceuticals Inc
  Stock Performance Chart for Aurinia Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 6.97
(Figures in Canadian Dollars)
1 Week 3.6%   13 Weeks 14.3%  
4 Weeks -10.3%   52 Weeks 108.1%  
Aurinia Pharmaceuticals Inc Key Data:
  Ticker: AUP Country: Canada
  Exchanges: TOR FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 228,592
(Year Ending Jan 2017).
Employees: 20
  Currency: Canadian Dollars Market Cap: 585,840,753
  Fiscal Yr Ends: December Shares Outstanding: 84,051,758
  Share Type: Common Closely Held Shares: 19,097,129
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.